Severe acute respiratory syndrome coronavirus 2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in coronavirus disease 2019 endemic areas: Prospective cross‐sectional study in Japan

Abstract

Objectives Gastrointestinal endoscopy (GIE) is useful for the early detection and treatment of many diseases; however, GIE is considered a high‐risk procedure in the coronavirus disease 2019 (COVID‐19) pandemic era. This study aimed to explore the rate of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) positivity in saliva and gastrointestinal fluids to which endoscopy medical staff are exposed. Methods The study was a single‐center cross‐sectional study. From June 1 to July 31, 2020, all patients who underwent GIE at Yokohama City University Hospital were registered. All patients provided 3 mL of saliva. For upper GIE, 10 mL of gastric fluid was collected through the endoscope. For lower GIE, 10 mL of intestinal fluid was collected through the endoscope. The primary outcome was the positive rate of SARS‐CoV‐2 in saliva and gastrointestinal fluids. We also analyzed serum‐specific antibodies for SARS‐CoV‐2 and patients’ background information. Results A total of 783 samples (560 upper GIE and 223 lower GIE samples) were analyzed. Polymerase chain reaction (PCR) on saliva samples did not show any positive results in either upper or lower GIE samples. However, 2.0% (16/783) of gastrointestinal fluid samples tested positive for SARS‐CoV‐2. No significant differences in age, sex, purpose of endoscopy, medication, or rate of antibody test positivity were found between PCR positive and PCR negative cases. Conclusions Asymptomatic patients, even those with no detectable virus in their saliva, had SARS‐CoV‐2 in their gastrointestinal tract. Endoscopy medical staff should be aware of infection when performing procedures. The study was registered as UMIN000040587.

Protective Effect of Food Against Inactivation of Human Coronavirus OC43 by Gastrointestinal Fluids

“…Our results are in accordance with the observations made in a study from COVID-19 patients undergoing gastrointestinal endoscopy, in which SARS-CoV-2 RNA was detected and quantified in the gastric fluid and intestinal fluids obtained (Miyake et al, 2021 ). This indirectly indicates that the virus was able to endure gastrointestinal fluids.…”

Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan

“…The symptoms of COVID-19 are variable but often include fever, cough, difficulty breathing, and lost senses of smell and taste. At least one-third of people infected with SARS-CoV-2 remain asymptomatic but are able to spread the virus, which primarily occurs via close personal contact . Therefore, many governments have implemented lockdowns or declared states of emergency to prevent the spread of SARS-CoV-2 …”

Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load

“…fueling concern among providers and patients alike 3 and leading to major long-term changes in workflow patterns and reconfiguration of operatories. 4 Regulators and health authorities based this guidance on studies reporting that aerosols are potential vehicles for transmission of respiratory pathogens, 5 and because severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified in saliva, [6][7][8] the potential for disease transmission through saliva has become a concern.…”